Case Study: a leading multinational biopharmaceutical company gains consumer insights on hemophilia gene therapy with C5i

Understanding Consumer Awareness and Perceptions about Gene Therapy for Hemophilia among EU5 Countries

A leading multinational biopharmaceutical company engaged C5i to address a critical challenge in launching a new gene therapy drug for hemophilia in key European markets. The customer needed to understand existing consumer awareness and perceptions to inform its product messaging and positioning strategy, aiming to reduce resistance and increase acceptance for this revolutionary treatment.

C5i implemented a solution using its AI and analytics capabilities to perform an extensive social listening analysis across the EU5 countries. By analyzing data from sources like Twitter, Reddit, and forums, C5i provided the client with critical insights, revealing that consumer sentiment was mostly negative due to significant concerns about safety, efficacy, and side effects. This intelligence directly informed the client's strategy, equipping them to message their product in a way that directly addressed the precise nature of patient concerns.